{ "access": { "embargo": { "active": false, "reason": null }, "files": "public", "record": "public", "status": "open" }, "created": "2024-04-26T15:49:24.201012+00:00", "custom_fields": { "code:codeRepository": "https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue2,Article108.pdf", "code:developmentStatus": { "id": "active", "title": { "en": "Active" } }, "journal:journal": { "issn": "0975-1556", "issue": "2", "pages": "681-688", "title": "International Journal of Pharmaceutical and Clinical Research", "volume": "16" } }, "deletion_status": { "is_deleted": false, "status": "P" }, "files": { "count": 1, "enabled": true, "entries": { "IJPCR,Vol16,Issue2,Article108.pdf": { "access": { "hidden": false }, "checksum": "md5:9e5e1a222a0bb776c39399841c63f576", "ext": "pdf", "id": "86ff0fbd-f8c9-48b0-a83f-d0d4eca9a823", "key": "IJPCR,Vol16,Issue2,Article108.pdf", "links": { "content": "https://zenodo.org/api/records/11074264/files/IJPCR,Vol16,Issue2,Article108.pdf/content", "iiif_api": "https://zenodo.org/api/iiif/record:11074264:IJPCR,Vol16,Issue2,Article108.pdf/full/full/0/default.png", "iiif_base": "https://zenodo.org/api/iiif/record:11074264:IJPCR,Vol16,Issue2,Article108.pdf", "iiif_canvas": "https://zenodo.org/api/iiif/record:11074264/canvas/IJPCR,Vol16,Issue2,Article108.pdf", "iiif_info": "https://zenodo.org/api/iiif/record:11074264:IJPCR,Vol16,Issue2,Article108.pdf/info.json", "self": "https://zenodo.org/api/records/11074264/files/IJPCR,Vol16,Issue2,Article108.pdf" }, "metadata": null, "mimetype": "application/pdf", "size": 422076, "storage_class": "L" } }, "order": [], "total_bytes": 422076 }, "id": "11074264", "is_draft": false, "is_published": true, "links": { "access": "https://zenodo.org/api/records/11074264/access", "access_grants": "https://zenodo.org/api/records/11074264/access/grants", "access_links": "https://zenodo.org/api/records/11074264/access/links", "access_request": "https://zenodo.org/api/records/11074264/access/request", "access_users": "https://zenodo.org/api/records/11074264/access/users", "archive": "https://zenodo.org/api/records/11074264/files-archive", "archive_media": "https://zenodo.org/api/records/11074264/media-files-archive", "communities": "https://zenodo.org/api/records/11074264/communities", "communities-suggestions": "https://zenodo.org/api/records/11074264/communities-suggestions", "doi": "https://doi.org/10.5281/zenodo.11074264", "draft": "https://zenodo.org/api/records/11074264/draft", "file_modification": "https://zenodo.org/api/records/11074264/file-modification", "files": "https://zenodo.org/api/records/11074264/files", "latest": "https://zenodo.org/api/records/11074264/versions/latest", "latest_html": "https://zenodo.org/records/11074264/latest", "media_files": "https://zenodo.org/api/records/11074264/media-files", "parent": "https://zenodo.org/api/records/11074263", "parent_doi": "https://doi.org/10.5281/zenodo.11074263", "parent_doi_html": "https://zenodo.org/doi/10.5281/zenodo.11074263", "parent_html": "https://zenodo.org/records/11074263", "preview_html": "https://zenodo.org/records/11074264?preview=1", "quota_increase": "https://zenodo.org/api/records/11074264/quota-increase", "request_deletion": "https://zenodo.org/api/records/11074264/request-deletion", "requests": "https://zenodo.org/api/records/11074264/requests", "reserve_doi": "https://zenodo.org/api/records/11074264/draft/pids/doi", "self": "https://zenodo.org/api/records/11074264", "self_doi": "https://doi.org/10.5281/zenodo.11074264", "self_doi_html": "https://zenodo.org/doi/10.5281/zenodo.11074264", "self_html": "https://zenodo.org/records/11074264", "self_iiif_manifest": "https://zenodo.org/api/iiif/record:11074264/manifest", "self_iiif_sequence": "https://zenodo.org/api/iiif/record:11074264/sequence/default", "thumbnails": { "10": "https://zenodo.org/api/iiif/record:11074264:IJPCR,Vol16,Issue2,Article108.pdf/full/%5E10,/0/default.jpg", "100": "https://zenodo.org/api/iiif/record:11074264:IJPCR,Vol16,Issue2,Article108.pdf/full/%5E100,/0/default.jpg", "1200": "https://zenodo.org/api/iiif/record:11074264:IJPCR,Vol16,Issue2,Article108.pdf/full/%5E1200,/0/default.jpg", "250": "https://zenodo.org/api/iiif/record:11074264:IJPCR,Vol16,Issue2,Article108.pdf/full/%5E250,/0/default.jpg", "50": "https://zenodo.org/api/iiif/record:11074264:IJPCR,Vol16,Issue2,Article108.pdf/full/%5E50,/0/default.jpg", "750": "https://zenodo.org/api/iiif/record:11074264:IJPCR,Vol16,Issue2,Article108.pdf/full/%5E750,/0/default.jpg" }, "versions": "https://zenodo.org/api/records/11074264/versions" }, "media_files": { "count": 1, "enabled": true, "entries": { "IJPCR,Vol16,Issue2,Article108.pdf.ptif": { "access": { "hidden": true }, "ext": "ptif", "id": "58bfedbc-b820-49d2-bbf1-c7d724eeeb80", "key": "IJPCR,Vol16,Issue2,Article108.pdf.ptif", "links": { "content": "https://zenodo.org/api/records/11074264/files/IJPCR,Vol16,Issue2,Article108.pdf.ptif/content", "self": "https://zenodo.org/api/records/11074264/files/IJPCR,Vol16,Issue2,Article108.pdf.ptif" }, "metadata": null, "mimetype": "application/octet-stream", "processor": { "source_file_id": "86ff0fbd-f8c9-48b0-a83f-d0d4eca9a823", "status": "finished", "type": "image-tiles" }, "size": 0, "storage_class": "L" } }, "order": [], "total_bytes": 0 }, "metadata": { "additional_descriptions": [ { "description": "

There has been accumulating awareness in the application of herbal medication that they may serve as a safe, effective and alternate treatment approach in the management of various diseases associated with pain and inflammation. Vitex negundo is one of such medicinal plants that has been of interest to many researchers and has been of use in traditional medicine. Vitex negundo is found in India, Sri Lanka, Madagascar, Malaysia, India, China and East Africa. Different parts, preparations and bioactive components of Vitex negundo  possess potential protective and therapeutic effects against various disease and related conditions – We review the present state of scientific knowledge on the potential use of Vitex negundo  and some of its bioactive components in protecting against various pathologies. Previous studies in various preclinical models, although limited in number and vary in design; seem to support the use of Vitex negundo and some of its active components in abdominal pain, asthma, cold, diarrhoea, indigestion, eye disorders, rheumatism, dysmenorrhea, headache, etc.
However, there is need for further preclinical and clinical studies to validate the use of Vitex negundo  and its active constituents in prevention and treatment of various diseases.  Additionally, since only a few Vitex negundo  compounds have been evaluated, specific effects or mechanisms of action and possible side effects of other     Vitex negundo  compounds need to be extensively evaluated. Also, this review delves into present commercial preparations of Vitex negundo which are mostly topical application preparations. However, further research, including large sampled randomised clinical trials, is essential to establish its safety and efficacy in human populations and to unlock its full therapeutic potential.

", "lang": { "id": "eng", "title": { "en": "English" } }, "type": { "id": "abstract", "title": { "de": "Abstract", "en": "Abstract" } } } ], "creators": [ { "affiliations": [ { "name": "Associate Professor, DRISHTI Research Unit, Maharashtra University of Health Sciences, Nashik" } ], "person_or_org": { "family_name": "Shweta Telang-Chaudhari", "name": "Shweta Telang-Chaudhari", "type": "personal" }, "role": { "id": "researcher", "title": { "de": "WissenschaftlerIn", "en": "Researcher" } } }, { "affiliations": [ { "name": "Professor & Head, Department of Pharmaceutical Medicine, Maharashtra University of Health Sciences, Nashik." } ], "person_or_org": { "family_name": "Jeetendra Singh", "name": "Jeetendra Singh", "type": "personal" }, "role": { "id": "researcher", "title": { "de": "WissenschaftlerIn", "en": "Researcher" } } }, { "affiliations": [ { "name": "Associate Professor, Department of Ayurveda Pharmaceutics, Matoshri Asarabai Darade Ayurveda College, Yeola, Nashik" } ], "person_or_org": { "family_name": "Hitesh Chaudhari", "name": "Hitesh Chaudhari", "type": "personal" }, "role": { "id": "researcher", "title": { "de": "WissenschaftlerIn", "en": "Researcher" } } }, { "affiliations": [ { "name": "Associate Professor, Department of Pharmaceutical Medicine, Maharashtra University of Health Sciences, Nashik" } ], "person_or_org": { "family_name": "Vaibhav Aher", "name": "Vaibhav Aher", "type": "personal" }, "role": { "id": "researcher", "title": { "de": "WissenschaftlerIn", "en": "Researcher" } } }, { "affiliations": [ { "name": "Professor & Head, Department of Ayurveda Pharmaceutics, Ayurveda Seva Sangh Ayurveda College, Nashik" } ], "person_or_org": { "family_name": "Shishir Pande", "name": "Shishir Pande", "type": "personal" }, "role": { "id": "researcher", "title": { "de": "WissenschaftlerIn", "en": "Researcher" } } } ], "dates": [ { "date": "2024-02-05", "type": { "id": "accepted", "title": { "de": "Angenommen", "en": "Accepted" } } } ], "description": "

There has been accumulating awareness in the application of herbal medication that they may serve as a safe, effective and alternate treatment approach in the management of various diseases associated with pain and inflammation. Vitex negundo is one of such medicinal plants that has been of interest to many researchers and has been of use in traditional medicine. Vitex negundo is found in India, Sri Lanka, Madagascar, Malaysia, India, China and East Africa. Different parts, preparations and bioactive components of Vitex negundo  possess potential protective and therapeutic effects against various disease and related conditions – We review the present state of scientific knowledge on the potential use of Vitex negundo  and some of its bioactive components in protecting against various pathologies. Previous studies in various preclinical models, although limited in number and vary in design; seem to support the use of Vitex negundo and some of its active components in abdominal pain, asthma, cold, diarrhoea, indigestion, eye disorders, rheumatism, dysmenorrhea, headache, etc.
However, there is need for further preclinical and clinical studies to validate the use of Vitex negundo  and its active constituents in prevention and treatment of various diseases.  Additionally, since only a few Vitex negundo  compounds have been evaluated, specific effects or mechanisms of action and possible side effects of other     Vitex negundo  compounds need to be extensively evaluated. Also, this review delves into present commercial preparations of Vitex negundo which are mostly topical application preparations. However, further research, including large sampled randomised clinical trials, is essential to establish its safety and efficacy in human populations and to unlock its full therapeutic potential.

", "identifiers": [ { "identifier": "https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue2,Article108.pdf", "scheme": "url" } ], "languages": [ { "id": "eng", "title": { "en": "English" } } ], "publication_date": "2024-02-28", "publisher": "International Journal of Pharmaceutical and Clinical Research", "references": [ { "reference": "1. Venkateswarlu K. Vitex negundo: Medicinal values, biological activities, toxicity studies and phytopharmacological actions. Int J Pharm Phytopharm Res 2012; 2: 126-33. 2. Suganthi N, Dubey S. Phytochemical constituents and pharmacological activities of Vitex negundo Linn. J Chem Pharm Res 2016; 8: 800- 7. 3. Li C.Z., Su Y.F., Jin X. Advances in Studies on Chemical Constituents from Plants of Vitex L.and Their Bioactivities. Chin. Tradit. Herb. Drugs. 2005; 36:930\u2013938 4. Dos Santos T.C., Schripsema J., Monache F.D., Leit\u00e3o S.G. Iridoids from Vitex Cymosa. J. Braz. Chem. Soc. 2001; 12:763\u2013766. 5. Suksamrarn A., Kumpun S., Kirtikara K., Yingyongnarongkul B., Suksamrarn S. Iridoids with Anti-Inflammatory Activity from Vitex Peduncularis. Planta Med. 2002; 68:72\u201373. 6. Khan A, Naz S, Farooq U, Shahid M, Ullah I, Ali I, Rauf A, Mabkhot YN. Bioactive chromone constituents from Vitex negundo alleviate pain and inflammation. J Pain Res. 2017 Dec 28; 11:95-102. 7. Mirghafourvand M., Mohammad-AlizadehCharandabi S., Ahmadpour P., Javadzadeh Y. Effects of Vitex Agnus and Flaxseed on Cyclic Mastalgia: A Randomized Controlled Trial. Complement. Ther. Med. 2016; 24:90\u201395. 8. Kulkarni RR, Virkar AD, D'mello P. Antioxidant and Anti-inflammatory Activity of Vitex negundo. Indian J Pharm Sci. 2008 Nov; 70(6): 838-40. doi: 10.4103/0250-474X.49140 9. Umamaheswari M, AsokKumar K, Somasundaram A, Sivashanmugam T, Subhadradevi V, Ravi TK. Xanthine oxidase inhibitory activity of some Indian medical plants. J Ethnopharmacol. 2007;109(3):547\u2013551 10. Arome D, Sunday AI, Onalike EI, Amarachi A. Pain and inflammation: management by conventional and herbal therapy. Indian J Pain. 2014;28(1):5\u201312 11. Maroon JC, Bost JW, Maroon A. Natural antiinflammatory agents for pain relief. Surg Neurol Int. 2010; 1:80 12. Wachtel-Galor S, Benzie IFF. Herbal Medicine: An Introduction to Its History, Usage, Regulation, Current Trends, and Research Needs. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 1. Available from: https://www.ncbi.nlm.nih.gov /books/NBK92773 13. Sharma. P.C, Yelne M.B. and Dennis T.J.- Database on Medicinal Plants used in Ayurveda, Vol-3, Published by CCRAS, Reprint-20 05,p451 14. Vishwanathan, A. S. & Ramaiah, Basavaraju. (2010). A Review on Vitex negundo L. \u2013 A Medicinally Important Plant. eJournal of Biological Sciences. 3. 30-42. 15. P. V. Sharma, \"Charak Samhita,\" Chaukhambha Orientalia, Varanasi, 1983. 16. Vishwanathan et al A review on Vitex negundo L. \u2013 A medicinally important plant 17. Arome D, Sunday AI, Onalike EI, Amarachi A. Pain and inflammation: management by conventional and herbal therapy. Indian J Pain. 2014;28(1):5\u201312. 18. Maroon JC, Bost JW, Maroon A. Natural antiinflammatory agents for pain relief. Surg Neurol Int. 2010; 1:80. 19. Keri RS, Budagumpi S, Pai RK, Balakrishna RG. Chromones as a privileged scaffold in drug discovery: a review. Eur J Med Chem. 20 14; 78:340\u2013374 20. Khan A, Naz S, Farooq U, Shahid M, Ullah I, Ali I, Rauf A, Mabkhot YN. Bioactive chromone constituents from Vitex negundo alleviate pain and inflammation. J Pain Res. 2017 Dec 28; 11:95-102. 21. Tirpude NV, Sharma A, Joshi R, Kumari M, Acharya V. Vitex negundo Linn. extract alleviates inflammatory aggravation and lung injury by modulating AMPK/PI3K/Akt/p38-NF-\u03baB and TGF-\u03b2/Smad/Bcl2/caspase/LC3 cascade and macrophages activation in murine model of OVA-LPS induced allergic asthma. J Ethnopharmacol. 2021 May 10;271:113894. 22. Zheng CJ, Zhao XX, Ai HW, Lin B, Han T, Jiang YP, Xing X, Qin LP. Therapeutic effects of standardized Vitex negundo seeds extract on complete Freund's adjuvant induced arthritis in rats. Phytomedicine. 2014 May 15;21(6):838- 46. 23. Singh, Pradeep & Mishra, Garima & Garg, Vipin & Kumar, Amit & Khosa, R. Anti-inflammatory activity of Vitex negundo root extract. Pharmacologyonline. 2009; 2. 772-781. 24. Yunos, Nurhanan & MA, Rasadah & Ong, Boo & Abas, Rafedah. Cytotoxicity Evaluations on Vitex negundo Anti-inflammatory Extracts. Malaysian Journal of Science. 2005;24. 213- 217. 25. Jana U. Chattopadhyay RN, Shaw B, Preliminary anti-inflammatory studies of Zingiber officinale Rose., Vitex negundo Linn. & Tinospora cordifolia (Willid) Miers in albino rats. Indian Journal of Pharmacology 1999; 31:232 233. 26. R.S. Telang, S. Chatterzee, C. Varsheneya, Studies on analgesic and anti \u2013 inflammatory activities of Vitex nigundo Linn, Indian J Pharmacology 1999;31:363-366. 27. Kariyawasam, K. W. J. C., Sirisena, P. D. N. N., Nanayakkara, H. L. C., Ratnasooriya, W. D., &Handunnetti, S. M. (2020). Vitex negundo L. leaf extract inhibits IL-6 and TNF-\u03b1 secretion and phagocytosis in human leukocytes. Journal of Herbal Medicine, 21, 100341. 28. Pandey A, Bani S, Satti NK, Gupta BD, Suri KA. Anti-arthritic activity of agnuside mediated through the down-regulation of inflammatory mediators and cytokines. Inflamm Res. 20 12; 61:293\u2013304. 29. Devi PR, Kumari K, Kokilavani C, Effect of Vitex negundo leaf extract on the free radical's scavengers in complete freund's adjuvant induced arthritic rats. Indian Journal of Clinical Biochemistry. 2007; 22 (1): 143-147. 30. Tiwari OP, Tripathi YB, Antioxidant properties of different fractions of Vitex negundo Linn. Food Chemistry. 2007; 100 (3): 1170-11 76. 31. Tandon VR. Medical uses and biological activities of Vitex negundo. Nat Prod Radiance. 2005; 4:162\u20135. 32. Rooban B, Lija Y, Biju P, Sasikala V, Sahasranamam V, Abraham A. Vitex negundo Attenuates Calpain Activation and Cataractogenesis in Selenite Models. Experimental Eye Research. 2009; 88:575-582. 33. Das B, Padhi MM, Singh OP, Deep VC, Tewari NS, Panda N. Clinical evaluation of nirgundi taila in the management of sandhivata. Anc Sci Life. 2003 Jul;23(1):22-34. 34. Joshi A, Mehta CS, Dave AR, Shukla VD. Clinical effect of Nirgundi Patra pinda sweda and Ashwagandhadi Guggulu Yoga in the management of Sandhigata Vata (Osteoarthritis). Ayu. 2011 Apr;32(2):207-12. 35. Rinchu RS, Chaitra. H. Therapeutic Review of Nirgundi in Ayurvedic Classics. International journal of health sciences and research Vol.9; Issue: 8; August 2019 36. Ali M, Shukla VD, Dave AR, Bhatt NN. A clinical study of Nirgundi Ghana Vati and Matra Basti in the management of Gridhrasi with special reference to sciatica. Ayu. 2010 Oct;31(4):456-60. 37. Ahuja, S. C., Siddharth Ahuja, and Uma Ahuja. \"Nirgundi (Vitex negundo)\u2013Nature's gift to mankind.\" Asian Agri-History 19.1 (2015): 5- 32. 38. Deshpande SV, Deshpande VS, Bhosale A, Kadam M. Conservative management of acute prolapsed inter-vertebral disc with ayurveda: A case report. J Ayurveda Integr Med. 2022 AprJun;13(2):100561. 39. Perveen S, Khan MA, Parveen R, Insaf A, Parveen B, Ahmad S, Husain SA. An Updated Review on Traditional and Modern Aspects of Vitex negundo. Current Traditional Medicine. 2023 Apr 1;9(2):114-27. 40. https://herbfinder.himalayawellness.in/vitexnegundo.htm 41. https://himalayawellness.in/products/antiseptic-cream 42. https://himalayawellness.in/products/himalayaayurveda-gum-care-toothpaste 43. Kulkarni, et al.: Antioxidant and antiinflammatory activity of Vitex negundo, Indian Journal of Pharmaceutical Sciences November - December 2000; 838-840 44. Dos Santos T.C., Schripsema J., Monache F.D., Leit\u00e3o S.G. Iridoids from Vitex Cymosa. J. Braz. Chem. Soc. 2001; 12:763\u2013766 45. Suksamrarn A., Kumpun S., Kirtikara K., Yingyongnarongkul B., Suksamrarn S. Iridoids with Anti-Inflammatory Activity from Vitex peduncularis. Planta Med. 2002; 68:72\u201373. 46. Raghavendra H. Lakshmanashetty, Chiang Mai, In vitro Antioxidant Activity of Vitex negundo L. Leaf Extracts J. Sci. 2010; 37(3): 489-497 47. Vinuchakkaravarthy T, Kumaravel KP, Ravichandran S, Velmurugan D. Active compound from the leaves of Vitex negundo L. Shows antiinflammatory activity with evidence of inhibition for secretory phospholipase A2 through molecular docking. Bioinformation. 2011;7(4): 199. 48. Zheng CJ, Zhao XX, Ai HW, Lin B, Han T, Jiang YP, Xing X, Qin LP. Therapeutic effects of standardized Vitex negundo seeds extract on complete Freund's adjuvant induced arthritis in rats. Phytomedicine. 2014 May 15;21(6):838- 46. 49. Ajmal Khan et al, Bioactive chromone constituents from Vitex negundo alleviate pain and inflammation Journal of Pain Research 2018 :11 95\u2013102 50. Cecilia C. et al Symptomatic treatment of mild COVID-19 with Vitex negundo (NIRPROMP formulation): A randomized, controlled clinical trial, Journal of Basic and Applied Pharmacology Vol. 2 No. 2 July-December2022;088-109. 51. Cortes-Maramba NP, Aquino HF, Del Rosario WA, Ramos SP, De Leon D, & DeLa Fuente DL, (0000). Clinical trial of vitex negundo tablet antitussive. Lagundi (Vitex negundo L.) monograph, 25-66 52. Alvero RGY, Alvero JR, Balaccua GP. Comparison of Efficacy and Safety of Vitex negundo 600 mg (Ascof\u00ae Forte) Capsules with Vitex negundo 600 mg (Ascof\u00ae Forte) Tablets in the Treatment of Acute Uncomplicated Cough among Filipino Adults in Cavite- Clinical Trial Phase 3b. Acta Med Philipp [Internet]. 2022Jul.15 [cited 2024Feb.12];56(12) 53. Nguyen, T. T., Do, P. T., Nguyen, L. T. N., & Pham, A. T. (2024). Acute and Sub-Chronic Toxicity Studies of Aqueous Ethanol Leaf Extract of Vitex negundo L in Experimental Animals: http://www.doi.org/10.26538/tjnpr/v8i1.14. Tropical Journal of Natural Product Research (TJNPR), 8(1), 5806\u20135810. 54. Dharmasiri MG, Jayakody JR, Galhena G, Liyanage SS, Ratnasooriya WD. Anti-inflammatory and analgesic activities of mature fresh leaves of Vitex negundo. J Ethnopha rmacol. 2003 Aug;87(2-3):199-206." } ], "resource_type": { "id": "publication-article", "title": { "de": "Zeitschriftenartikel", "en": "Journal article" } }, "rights": [ { "description": { "en": "The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited." }, "icon": "cc-by-icon", "id": "cc-by-4.0", "props": { "scheme": "spdx", "url": "https://creativecommons.org/licenses/by/4.0/legalcode" }, "title": { "en": "Creative Commons Attribution 4.0 International" } } ], "title": "Vitex negundo Linn (Nirgundi): Journey from Past to Future Therapeutic Prospects", "version": "https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue2,Article108.pdf" }, "parent": { "access": { "owned_by": { "user": "578652" }, "settings": { "accept_conditions_text": null, "allow_guest_requests": false, "allow_user_requests": false, "secret_link_expiration": 0 } }, "communities": {}, "id": "11074263", "pids": { "doi": { "client": "datacite", "identifier": "10.5281/zenodo.11074263", "provider": "datacite" } } }, "pids": { "doi": { "client": "datacite", "identifier": "10.5281/zenodo.11074264", "provider": "datacite" }, "oai": { "identifier": "oai:zenodo.org:11074264", "provider": "oai" } }, "revision_id": 6, "stats": { "all_versions": { "data_volume": 110161836.0, "downloads": 261, "unique_downloads": 238, "unique_views": 423, "views": 438 }, "this_version": { "data_volume": 110161836.0, "downloads": 261, "unique_downloads": 238, "unique_views": 423, "views": 438 } }, "status": "published", "swh": {}, "updated": "2024-07-06T05:12:04.057465+00:00", "versions": { "index": 1, "is_latest": true } }